Clinical Trials Directory

Trials / Completed

CompletedNCT03419273

Adipose Tissue Inflammation in Individuals Undergoing Bariatric Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

A growing body of work done over the past few decades has established that adipose tissue as an active endocrine organ which secretes a wide range of metabolic and immunological factors collectively called "adipokines (1)." Importantly, these secreted factors enter into the circulation and have paracrine and autocrine actions, which profoundly impact systemic metabolism (e.g., insulin sensitivity). Additionally, in animals, loss of ovarian hormone production via ovariectomy (similar to menopause in humans) leads to increases in both in adipose tissue mass and in adipose tissue inflammation (2) making this tissue less healthy than that from premenopausal animals. To date, no studies have investigated the effect of menopause on abdominal fat in overweight individuals. Knowing if adipose tissue-specific changes occur with menopause may potentially lead to recommendations or therapeutics to improve women's health post menopause.

Detailed description

Subjects will just have to agree to having a small amount of adipose tissue being removed during the bariatric surgery. The investigators will also collect a blood sample at that time. There will be no other visits for the subject.

Conditions

Interventions

TypeNameDescription
PROCEDUREbariatric surgeryWe are recruiting only those going through bariatric surgery

Timeline

Start date
2017-07-01
Primary completion
2019-03-31
Completion
2019-07-01
First posted
2018-02-01
Last updated
2019-10-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03419273. Inclusion in this directory is not an endorsement.